chr20-44625580-C-A

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate

The NM_000022.4(ADA):​c.467G>T​(p.Arg156Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R156H) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ADA
NM_000022.4 missense

Scores

13
5
1

Clinical Significance

Pathogenic criteria provided, single submitter P:1U:1

Conservation

PhyloP100: 7.54

Publications

6 publications found
Variant links:
Genes affected
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
ADA Gene-Disease associations (from GenCC):
  • severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Myriad Women’s Health, Orphanet
  • Omenn syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM1
In a hotspot region, there are 3 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000022.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr20-44625580-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 1984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.989
PP5
Variant 20-44625580-C-A is Pathogenic according to our data. Variant chr20-44625580-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 555823.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADANM_000022.4 linkc.467G>T p.Arg156Leu missense_variant Exon 5 of 12 ENST00000372874.9 NP_000013.2
ADANM_001322051.2 linkc.467G>T p.Arg156Leu missense_variant Exon 5 of 11 NP_001308980.1
ADANR_136160.2 linkn.559G>T non_coding_transcript_exon_variant Exon 5 of 11
ADANM_001322050.2 linkc.73+876G>T intron_variant Intron 4 of 10 NP_001308979.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAENST00000372874.9 linkc.467G>T p.Arg156Leu missense_variant Exon 5 of 12 1 NM_000022.4 ENSP00000361965.4
ADAENST00000696038.1 linkn.*213G>T non_coding_transcript_exon_variant Exon 5 of 9 ENSP00000512344.1
ADAENST00000696038.1 linkn.*213G>T 3_prime_UTR_variant Exon 5 of 9 ENSP00000512344.1
ADAENST00000695995.1 linkc.217-2502G>T intron_variant Intron 3 of 8 ENSP00000512318.1
ADAENST00000695991.1 linkc.217-2650G>T intron_variant Intron 3 of 7 ENSP00000512314.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1429110
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
707846
African (AFR)
AF:
0.00
AC:
0
AN:
32922
American (AMR)
AF:
0.00
AC:
0
AN:
40278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25426
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38280
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50944
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4520
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1095964
Other (OTH)
AF:
0.00
AC:
0
AN:
59054
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency Pathogenic:1Uncertain:1
Dec 31, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg156 amino acid residue in ADA. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1284479, 8227344, 9758612, 22447032). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ADA protein function. ClinVar contains an entry for this variant (Variation ID: 555823). This missense change has been observed in individual(s) with severe combined immunodeficiency with adenosine deaminase deficiency (PMID: 20039061). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 156 of the ADA protein (p.Arg156Leu). -

Dec 22, 2017
Counsyl
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.73
BayesDel_addAF
Pathogenic
0.54
D
BayesDel_noAF
Pathogenic
0.54
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.98
D;D
Eigen
Pathogenic
0.93
Eigen_PC
Pathogenic
0.88
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
D;D
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.0
H;.
PhyloP100
7.5
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-5.1
D;D
REVEL
Pathogenic
0.94
Sift
Uncertain
0.016
D;D
Sift4G
Uncertain
0.054
T;T
Polyphen
0.97
D;.
Vest4
0.97
MutPred
0.90
Loss of MoRF binding (P = 0.0092);Loss of MoRF binding (P = 0.0092);
MVP
0.96
MPC
0.68
ClinPred
1.0
D
GERP RS
5.6
Varity_R
0.87
gMVP
0.92
Mutation Taster
=1/99
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121908722; hg19: chr20-43254221; API